Nexus NeroTech Ventures, a brain-health venture capital fund with $200 million in assets, has shut its doors as of March 31.
The VC firm, which was backed by Google co-founder Sergey Brin, is in the process of being merged into Brin’s family office, Bayshore Global Management, Bloomberg reported.
Through his nonprofit Catalyst4, Brin supported Nexus along with several other venture funds. A 2024 tax filing indicated that Catalyst4 held roughly a 95% stake across multiple Nexus investment vehicles.
The VC firm, Nexus, had approximately 15 companies in its portfolio.
“Our companies have already helped more than 200,000 individuals. In addition, the body of clinical studies arising from this portfolio — currently 50+ ongoing studies — demonstrates the strong pipeline that has been created, providing a rigorous scientific foundation that has already yielded significant breakthroughs,” Parramon wrote.
Brin is currently the world’s fourth-richest individual, with a net worth of $269 billion, according to the Bloomberg Billionaires Index.
The Google co-founder has spent decades supporting brain research, including studies on Parkinson’s disease, a central focus of his philanthropy.
Forbes reported Brin has contributed at least $1.75 billion toward advancing understanding of the condition, driven by his own genetic risk mutation and his mother’s diagnosis. Brin has also invested in studies for autism and bipolar disorder.
Photo: REC and ROLL Stock via Shutterstock
Market News and Data brought to you by Benzinga APIs
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.